Rankings · Price against the business

A-graded, furthest below their high

Graded A, ranked by how far the share price sits below its 52-week high. The grade is built from the filings alone; the fall is a fact about the price, not the business.

99 companies meet this test

Figures as of October 1, 2026

#CompanyGradeBelow 52-week highP/EMarket value
1ALHCALIGNMENT HEALTHCARE, INC.A-68%41.68$1.6B
2DOCSDoximity, Inc.A+-65%31.20$5.1B
3HIMSHIMS & HERS HEALTH, INC.A--54%—$6.6B
4ZTSZoetis Inc.A+-51%11.58$29B
5ADMAADMA BIOLOGICS, INC.A+-51%14.24$2.2B
6ALNYALNYLAM PHARMACEUTICALS, INC.A+-48%128.95$34B
7ENOVEnovis CorpA--44%—$1.1B
8IRTCiRhythm Holdings, Inc.A--40%—$3.8B
9ACADACADIA PHARMACEUTICALS INC.A+-34%9.07$3.5B
10OMCLOMNICELL, INCA-33%40.79$1.6B
11COOThe Cooper Companies, Inc.A-33%19.39$10.8B
12ISRGIntuitive Surgical, Inc.A+-30%47.27$145.6B
13IDXXIDEXX LABORATORIES INC /DEA+-30%37.49$42B
14ARDTArdent Health, Inc.A-30%19.29$1.5B
15OMDAOmada Health, Inc.A-28%84.17$1.2B
16SYKSTRYKER CORPA+-28%28.90$107B
17DVADAVITA INC.A-27%14.41$11.2B
18ALGNALIGN TECHNOLOGY, INC.A-27%25.09$10.2B
19BHCBausch Health Companies Inc.A-27%—$2.2B
20SNNSmith & Nephew plcA-26%18.82$11.8B
21GRFSGrifols SAA-26%27.95$5B
22INNVInnovAge Holding Corp.A-26%—$1.2B
23MGTXMeiraGTx Holdings plcA-26%15.67$1.1B
24BCRXBIOCRYST PHARMACEUTICALS, INC.A-26%—$2.1B
25NBIXNEUROCRINE BIOSCIENCES INCA+-25%20.29$14.1B

More rankings

A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.